Revenue | ₹2,104.23Cr |
Net Profits | ₹206.95Cr |
Net Profit Margins | 9.83% |
Emcure Pharmaceuticals Ltd’s revenue jumped 14.45% since last year same period to ₹2,104.23Cr in the Q1 2025-2026. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated -0.78% fall in its revenue since last 3-months.
Emcure Pharmaceuticals Ltd’s net profit jumped 43.64% since last year same period to ₹206.95Cr in the Q1 2025-2026. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 9.52% jump in its net profits since last 3-months.
Emcure Pharmaceuticals Ltd’s net profit margin jumped 25.5% since last year same period to 9.83% in the Q1 2025-2026. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 10.38% jumped in its net profit margins since last 3-months.
The revenue for Emcure Pharmaceuticals Ltd in the Q1 results 2025 was ₹2,104.23Cr.
The net profit for Emcure Pharmaceuticals Ltd in the Q1 results 2025 was ₹206.95Cr.
The net profit margin for Emcure Pharmaceuticals Ltd in the Q1 results 2025 was 9.83%.
The revenue for Emcure Pharmaceuticals Ltd in the Q1 results 2024 was ₹1,838.58Cr.
The net profit for Emcure Pharmaceuticals Ltd in the Q1 results 2024 was ₹144.08Cr.
The net profit margin for Emcure Pharmaceuticals Ltd in the Q1 results 2024 was 7.84%.